In addition to targeting COVID-19 through both nuclear receptor-dependent and-independent mechanisms, new CYP11A1-derived active forms of vitamin D and lumisterol can be used as antiviral drugs and supplements to prevent and attenuate it [69]. This evidence concerns the gene CYP11A1 and COVID-19.